Poulvac Ovoline CVI
بولفاك أوفولين سي في آي لقاح مرض ماريك بالحقن داخل البيض
Poulvac Ovoline CVI is a frozen, cell-associated live virus vaccine containing the attenuated Rispens CVI 988 strain of Marek's Disease Virus (Serotype 1). Formulated for in-ovo injection into 18-to-19-day-old embryonated broiler/layer eggs or subcutaneous injection in day-old chicks to provide early and robust protection against very virulent Marek's disease (vvMDV).
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Glass ampoules of 1,000, 2,000, and 4,000 doses stored in liquid nitrogen canisters
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Poultry | 0.05 mL per egg in-ovo at 18 to 19 days of incubation, or 0.2 mL per chick subcutaneously at day of age | In-ovo injection or Subcutaneous (SC) | Single application |
Withdrawal Periods
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Poultry | 21 |
Indications
-
Active immunization of embryonated chicken eggs or day-old chicks to prevent mortality, lesions, and immunosuppression caused by Marek's disease virus.
Contraindications
-
Do not vaccinate compromised embryonated eggs or sickly chicks.
Precautions
-
Handling liquid nitrogen requires face shield and cryo-protective gloves to prevent frostbite.
-
Once reconstituted, use vaccine within 2 hours.
Side Effects
-
None when administered following correct hatchery hygiene and protocols.
Images
Documents
-
Download
Poulvac Ovoline CVI Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
No data available
Information has not been added yet.
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.